177 related articles for article (PubMed ID: 25083793)
21. Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp
Ferreira RC; Castro Dopico X; Oliveira JJ; Rainbow DB; Yang JH; Trzupek D; Todd SA; McNeill M; Steri M; Orrù V; Fiorillo E; Crouch DJM; Pekalski ML; Cucca F; Tree TI; Vyse TJ; Wicker LS; Todd JA
Front Immunol; 2019; 10():2606. PubMed ID: 31781109
[TBL] [Abstract][Full Text] [Related]
22. The Treg-specific demethylated region stabilizes Foxp3 expression independently of NF-κB signaling.
Schreiber L; Pietzsch B; Floess S; Farah C; Jänsch L; Schmitz I; Huehn J
PLoS One; 2014; 9(2):e88318. PubMed ID: 24505473
[TBL] [Abstract][Full Text] [Related]
23. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
24. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
[TBL] [Abstract][Full Text] [Related]
25. Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome.
Barzaghi F; Passerini L; Gambineri E; Ciullini Mannurita S; Cornu T; Kang ES; Choe YH; Cancrini C; Corrente S; Ciccocioppo R; Cecconi M; Zuin G; Discepolo V; Sartirana C; Schmidtko J; Ikinciogullari A; Ambrosi A; Roncarolo MG; Olek S; Bacchetta R
J Autoimmun; 2012 Feb; 38(1):49-58. PubMed ID: 22264504
[TBL] [Abstract][Full Text] [Related]
26. Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival.
Zhuo C; Li Z; Xu Y; Wang Y; Li Q; Peng J; Zheng H; Wu P; Li B; Cai S
Mol Cancer; 2014 Jun; 13():153. PubMed ID: 24938080
[TBL] [Abstract][Full Text] [Related]
27. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease.
Jia L; Zhu L; Wang JZ; Wang XJ; Chen JZ; Song L; Wu YJ; Sun K; Yuan ZY; Hui R
Atherosclerosis; 2013 Jun; 228(2):346-52. PubMed ID: 23566804
[TBL] [Abstract][Full Text] [Related]
28. Cord blood Tregs with stable FOXP3 expression are influenced by prenatal environment and associated with atopic dermatitis at the age of one year.
Hinz D; Bauer M; Röder S; Olek S; Huehn J; Sack U; Borte M; Simon JC; Lehmann I; Herberth G;
Allergy; 2012 Mar; 67(3):380-9. PubMed ID: 22187950
[TBL] [Abstract][Full Text] [Related]
29. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
30. Impact of 5-aza-2'-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cells.
Kehrmann J; Tatura R; Zeschnigk M; Probst-Kepper M; Geffers R; Steinmann J; Buer J
Immunology; 2014 Jul; 142(3):384-95. PubMed ID: 24476360
[TBL] [Abstract][Full Text] [Related]
31. Methylation-Sensitive Restriction Enzyme Quantitative Polymerase Chain Reaction Enables Rapid, Accurate, and Precise Detection of Methylation Status of the Regulatory T Cell (Treg)-Specific Demethylation Region in Primary Human Tregs.
Perry N; Wasko K; Cheng J; Tabbaa D; Marco E; Giannoukos G; Albright CF; Borges CM
J Immunol; 2021 Jan; 206(2):446-451. PubMed ID: 33277386
[TBL] [Abstract][Full Text] [Related]
32. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
[TBL] [Abstract][Full Text] [Related]
33. DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis.
Wang YY; Wang Q; Sun XH; Liu RZ; Shu Y; Kanekura T; Huang JH; Li YP; Wang JC; Zhao M; Lu QJ; Xiao R
Br J Dermatol; 2014 Jul; 171(1):39-47. PubMed ID: 24641670
[TBL] [Abstract][Full Text] [Related]
34. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
[TBL] [Abstract][Full Text] [Related]
35. [Phenomena and pathological significances of the methylated p16 promotor in DNA derived from plasma and blood cells of patients with systemic lupus erythematosus].
Li AS; Li YM; Yang AZ; Yao X; Chen ZQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):675-81. PubMed ID: 17121230
[TBL] [Abstract][Full Text] [Related]
36. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
Hahn BH; Anderson M; Le E; La Cava A
Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells.
Wilk C; Effenberg L; Abberger H; Steenpass L; Hansen W; Zeschnigk M; Kirschning C; Buer J; Kehrmann J
Cell Immunol; 2022 Jan; 371():104471. PubMed ID: 34954490
[TBL] [Abstract][Full Text] [Related]
38. Detection of CD4+ CD25+ FOXP3+ regulatory T cells in peripheral blood of patients with chronic autoimmune urticaria.
Sun RS; Sui JF; Chen XH; Ran XZ; Yang ZF; Guan WD; Yang T
Australas J Dermatol; 2011 Aug; 52(3):e15-8. PubMed ID: 21834806
[TBL] [Abstract][Full Text] [Related]
39. Treg-specific demethylated region activity in isolated regulatory t lymphocytes is a surrogate for disease severity in hepatocellular carcinoma.
Liu HR; Li WM
IUBMB Life; 2015 May; 67(5):355-60. PubMed ID: 25907075
[TBL] [Abstract][Full Text] [Related]
40. The status of FOXP3 gene methylation in pediatric systemic lupus erythematosus.
Hanaei S; Sanati G; Zoghi S; Gharibzadeh S; Ziaee V; Rezaei N
Allergol Immunopathol (Madr); 2020; 48(4):332-338. PubMed ID: 32475613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
